Team builders for your success.
Bourne Partners Advises Prophase Labs, Inc. On Agreement To Sell Cold-EEZE(R) Brand
Prophase Labs has agreed to sell its Cold-EEZE® cold remedy brand to a wholly owned subsidiary of Mylan N.V. Read More
Bourne Partners Publishes Specialty Pharma Report
The full report includes a detailed market overview, current market trends, and a collection of future growth drivers within the space. Read More
Bourne Partners and Carlyle Team to Build Global Pharma Platform
The Carlyle Group and Bourne Partners Form Phoenix Therapeutics to Build Global Pharma Company Read More